Cytokinetics ends FORTITUDE-ALS trial enrolment
Cytokinetics has completed patient enrolment in the FORTITUDE-ALS trial, a Phase ll clinical study of...
Cytokinetics has completed patient enrolment in the FORTITUDE-ALS trial, a Phase ll clinical study of...